Skip to main content
. Author manuscript; available in PMC: 2015 Dec 15.
Published in final edited form as: Oral Oncol. 2014 Oct 11;50(12):1149–1156. doi: 10.1016/j.oraloncology.2014.09.013

Figure 6. Effect of Minnelide on tumor progression in 2 different xenograft mouse models. (A).

Figure 6

In the cell injection xenograft model, Minnelide significantly decreased tumor progression, as compared with the saline control group. Statistically difference starts at 16 days (P < 0.0126*) and is sustained through out the experiment. (B) In the patient-derived tumor xenograft model, Minnelide significantly decreased tumor progression, as compared with the saline control group beginning at day 14 (P < 0.0176*) and sustained to the end of the experiment.